Titanium-mediated amination of Grignard reagents using primary and secondary amines

Angewandte Chemie - International Edition

Volumn 50, Issue 36, 2011, Pages 8325-8328

  Barker, Timothy J ^a   Jarvo, Elizabeth R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amination; anilines; Grignard reagents; N chloroamines; titanium

Indexed keywords

ANDROGEN RECEPTORS; ANILINE DERIVATIVES; FUNCTIONALIZATIONS; GRIGNARD REAGENT; GRIGNARD REAGENTS; N-CHLOROAMINES; N-CHLOROSUCCINIMIDE; PRIMARY AND SECONDARY AMINE;

ANILINE; ORGANIC COMPOUNDS;

TITANIUM;

AMINE; ANDROGEN; ANDROGEN RECEPTOR; ANILINE; ANILINE DERIVATIVE; N CHLOROSUCCINIMIDE; N-CHLOROSUCCINIMIDE; SUCCINIMIDE DERIVATIVE; TITANIUM;

AMINATION; ARTICLE; CATALYSIS; CHEMISTRY; METABOLISM;

AMINATION; AMINES; ANDROGENS; ANILINE COMPOUNDS; CATALYSIS; RECEPTORS, ANDROGEN; SUCCINIMIDES; TITANIUM;

EID: 80052086313     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201103700     Document Type: Article

References (49)

1. S. V. Ley, A. W. Thomas, Angew. Chem. 2003, 115, 5558-5607
2. Angew. Chem. Int. Ed. 2003, 42, 5400-5449
3. J. P. Wolfe, S. Wagaw, J.-F. Marcoux, S. L. Buchwald, Acc. Chem. Res. 1998, 31, 805-818
4. J. F. Hartwig, Angew. Chem. 1998, 110, 2154-2177
5. Angew. Chem. Int. Ed. 1998, 37, 2046-2067
6. A. R. Muci, S. L. Buchwald, Top. Curr. Chem. 2002, 219, 131-209
7. S. Tasler, B. H. Lipshutz, J. Org. Chem. 2003, 68, 1190-1199
8. I. P. Beletskaya, A. V. Cheprakov, Coord. Chem. Rev. 2004, 248, 2337-2364.
9. I. D. G. Watson, A. K. Yudin, Curr. Opin. Drug Discovery Dev. 2002, 5, 906-917
10. P. Dembeck, G. Seconi, A. Ricci, Chem. Eur. J. 2000, 6, 1281-1286
11. E. Erdik, M. Ay, Chem. Rev. 1989, 89, 1947-1980; see also
12. J. A. Smulik, E. Vedejs, Org. Lett. 2003, 5, 4187-4190
13. C. Greck, L. Bischoff, F. Ferreira, J. P. Genêt, J. Org. Chem. 1995, 60, 7010-7012
14. P. Bernardi, P. Dembech, G. Fabbri, A. Ricci, G. Seconi, J. Org. Chem. 1999, 64, 641-643
15. I. Sapountzis, P. Knochel, Angew. Chem. 2004, 116, 915-918
16. Angew. Chem. Int. Ed. 2004, 43, 897-900.
17. A. M. Berman, J. S. Johnson, J. Am. Chem. Soc. 2004, 126, 5680-5681
18. A. M. Berman, J. S. Johnson, J. Org. Chem. 2005, 70, 364-366
19. A. M. Berman, J. S. Johnson, J. Org. Chem. 2006, 71, 219-224
20. M. J. Campbell, J. S. Johnson, Org. Lett. 2007, 9, 1521-1524
21. A. M. Berman, J. S. Johnson, Synlett 2005, 1799-1801.
22. For an example of one-pot oxidation to O-benzoyl hydroxylamines and cross-coupling, see:, E. J. Yoo, S. Ma, T.-S. Mei, K. S. L. Chan, J.-Q. Yu, J. Am. Chem. Soc. 2011, 133, 7652-7655.
23. C. He, C. Chen, J. Cheng, C. Liu, W. Liu, Q. Li, A. Lei, Angew. Chem. 2008, 120, 6514-6517
24. Angew. Chem. Int. Ed. 2008, 47, 6414-6417
25. T. Kawano, K. Hirano, T. Satoh, M. Miura, J. Am. Chem. Soc. 2010, 132, 6900-6901.
26. S. Zhou, C.-R. Chen, H.-M. Gau, Org. Lett. 2010, 12, 48-51
27. D. J. Ramón, M. Yus, Chem. Rev. 2006, 106, 2126-2208
28. C. García, P. J. Walsh, Org. Lett. 2003, 5, 3641-3644
29. B. Weber, D. Seebach, Tetrahedron 1994, 50, 7473-7484.
30. T. E. Müller, K. C. Hultzsch, M. Yus, F. Foubelo, M. Tada, Chem. Rev. 2008, 108, 3795-3892
31. R. Severin, S. Doye, Chem. Soc. Rev. 2007, 36, 1407-1420
32. S. Doye, Synlett 2004, 1653-1672
33. A. V. Lee, L. L. Schafer, Eur. J. Inorg. Chem. 2007, 2243-2255
34. C. Müller, W. Saak, S. Doye, Eur. J. Org. Chem. 2008, 2731-2738
35. Titanium-mediated transfer of alkenyl groups from alcohols for the synthesis of secondary amines:, B. Ramanathan, A. L. Odom, J. Am. Chem. Soc. 2006, 128, 9344-9345.
36. 4 has been shown to promote oxidative coupling of anilines at the 4-position:, M. Periasamy, K. N. Jayakumar, P. Bharathi, J. Org. Chem. 2000, 65, 3548-3550.
37. N-Butylamine gave desired product in 44% yield. Unbranched N-chloroamines are prone to polymerization, see:, J. C. Guillemin, J. M. Denis, Synthesis 1985, 1131-1133.
38. benign prostatic hyperplasia:, J. A. Tucker, D. A. Allwine, K. C. Grega, M. R. Barbachyn, J. L. Klock, J. L. Adamski, S. J. Brickner, D. K. Hutchinson, C. W. Ford, G. E. Zurenko, R. A. Conradi, P. S. Burton, R. M. Jensen, J. Med. Chem. 1998, 41, 3727-3735
39. cardiovascular disease by inhibiting plasminogen activator inhibitor (PAI-1):, B. Ye, Y.-L. Chou, R. Karanjawala, W. Lee, S.-F. Lu, K. J. Shaw, S. Jones, D. Lentz, A. Liang, J.-L. Tseng, Q. Wu, Z. Zhao, Bioorg. Med. Chem. Lett. 2004, 14, 761-765
40. bacterial infections:, A. Sarswat, R. Kumar, L. Kumar, N. Lal, S. Sharma, Y. S. Prabhakar, S. K. Pandey, J. Lal, V. Verma, A. Jain, Maikhuri, D. Dalcla, Kirti, G. Gupta, V. L. Sharma, J. Med. Chem. 2011, 54, 302-311.
41. N-Arylhomopiperazines have been used as CXCR3 antagonists for the treatment of inflammatory disorders such as multiple sclerosis and rheumatoid arthritis:, A. G. Cole, I. L. Stroke, M.-R. Brescia, S. Simhadri, J. J. Zhang, Z. Hussain, M. Snider, C. Haskell, S. Ribeiro, K. C. Appell, I. Henderson, M. L. Webb, Bioorg. Med. Chem. Lett. 2006, 16, 200-203.
42. for Br-Mg exchange:, A. Krasovskiy, P. Knochel, Angew. Chem. 2004, 116, 3396-3399
43. Angew. Chem. Int. Ed. 2004, 43, 3333-3336
44. for I-Mg exchange:, L. Boymond, M. Rottlander, G. Cahiez, P. Knochel, Angew. Chem. 1998, 110, 1801-1803
45. Angew. Chem. Int. Ed. 1998, 37, 1701-1703.
46. A. Morales, J. L. Tenover, Urol. Clinics North Am. 2002, 29, 975-982
47. A. Hobisch, Z. Culig, C. Radmayr, G. Bartsch, H. Klocker, A. Hittmair, Cancer Res. 1995, 55, 3068-3072
48. C. D. Chen, D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, C. L. Sawyers, Nat. Med. 2004, 10, 33-39.
49. R. P. Trump, J.-B. E. Blanc, E. L. Stewart, P. J. Brown, M. Caivano, D. W. Gray, W. J. Hoekstra, T. M. Willson, B. Han, P. Turnbull, J. Comb. Chem. 2007, 9, 107-114.